Myeloid cell-targeted therapies for solid tumours

S Goswami, S Anandhan, D Raychaudhuri… - Nature Reviews …, 2023 - nature.com
Myeloid cells are the most abundant immune components of the tumour microenvironment,
where they have a variety of functions, ranging from immunosuppressive to …

Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy

L Yang, A Li, Y Wang, Y Zhang - Signal Transduction and Targeted …, 2023 - nature.com
Microorganisms, including bacteria, viruses, fungi, and other eukaryotes, play critical roles in
human health. An altered microbiome can be associated with complex diseases …

The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer

G Mirji, A Worth, SA Bhat, M El Sayed, T Kannan… - Science …, 2022 - science.org
The composition of the gut microbiome can control innate and adaptive immunity and has
emerged as a key regulator of tumor growth, especially in the context of immune checkpoint …

STING-induced regulatory B cells compromise NK function in cancer immunity

S Li, B Mirlekar, BM Johnson, WJ Brickey, JA Wrobel… - Nature, 2022 - nature.com
An immunosuppressive tumour microenvironment is a major obstacle in the control of
pancreatic and other solid cancers,–. Agonists of the stimulator of interferon g enes (STING) …

Turning up the heat on non-immunoreactive tumours: opportunities for clinical development

MO de Olza, BN Rodrigo, S Zimmermann… - The Lancet …, 2020 - thelancet.com
Notable advances have been achieved in the treatment of cancer since the advent of
immunotherapy, and immune checkpoint inhibitors have shown clinical benefit across a …

Engineered PLGA microparticles for long-term, pulsatile release of STING agonist for cancer immunotherapy

X Lu, L Miao, W Gao, Z Chen, KJ McHugh… - Science translational …, 2020 - science.org
Activation of the stimulator of interferon gene (STING) pathway within the tumor
microenvironment has been shown to generate a strong antitumor response. Although local …

The cGAS-STING pathway: a promising immunotherapy target

L Ou, A Zhang, Y Cheng, Y Chen - Frontiers in immunology, 2021 - frontiersin.org
With the continuous development of immunotherapy, researchers have paid more attention
to the specific immune regulatory mechanisms of various immune responses in different …

Novel strategies for cancer immunotherapy: counter-immunoediting therapy

S Liu, Q Sun, X Ren - Journal of Hematology & Oncology, 2023 - Springer
The advent of immunotherapy has made an indelible mark on the field of cancer therapy,
especially the application of immune checkpoint inhibitors in clinical practice. Although …

STING: a master regulator in the cancer-immunity cycle

Y Zhu, X An, X Zhang, Y Qiao, T Zheng, X Li - Molecular cancer, 2019 - Springer
The aberrant appearance of DNA in the cytoplasm triggers the activation of cGAS-cGAMP-
STING signaling and induces the production of type I interferons, which play critical roles in …

POLQ inhibition elicits an immune response in homologous recombination–deficient pancreatic adenocarcinoma via cGAS/STING signaling

G Oh, A Wang, L Wang, J Li, G Werba… - The Journal of …, 2023 - Am Soc Clin Investig
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy that harbors
mutations in homologous recombination–repair (HR-repair) proteins in 20%–25% of cases …